NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets
- NHS England
Procurement identifier (OCID): ocds-h6vhtk-0668c0
Description
Project title: NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets
Offer reference number: CM/TNS/26/5745
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
CM/TNS/26/5745 Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg
Lot 1 DNE, LNW & SOFE 1 November 2026 to 31 October 2027 (12 months)
Lot 2 DNW & MAE 1 November 2026 to 31 October 2027 (12 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Notices
UK7: Contract details notice
- Notice identifier
- 2026/S 000-083119
- Published
- 2 September 2026, 2:59pm
UK6: Contract award notice
- Notice identifier
- 2026/S 000-071842
- Published
- 29 July 2026, 3:55pm
UK4: Tender notice
- Notice identifier
- 2026/S 000-052395
- Published
- 3 June 2026, 2:19pm
UK2: Preliminary market engagement notice
- Notice identifier
- 2026/S 000-030757
- Published
- 2 April 2026, 11:05am
UK1: Pipeline notice
- Notice identifier
- 2026/S 000-022494
- Published
- 12 March 2026, 3:56pm